[{"from": "human", "value": "Please give me some details about this molecule. [C][N][C][C][N][Branch1][Branch2][C][=Branch1][C][=O][C][Ring1][#Branch1][C][C][=C][Branch2][Ring2][#Branch1][N][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][C][C][N][Ring1][#Branch1][C][=Branch1][C][=O][N][C][=N][C][=C][Branch1][N][C][=Branch1][Ring2][=C][Ring1][=Branch1][N][C][C][O][C][C][#N][C][=O]"}, {"from": "gpt", "value": "The molecule is an inhibitor of human fibroblast growth factor receptor 4 (FGFR4), with potential antineoplastic activity. Upon administration, roblitinib binds to and inhibits the activity of FGFR4, which leads to an inhibition of tumor cell proliferation in FGFR4-overexpressing cells. FGFR4 is a receptor tyrosine kinase upregulated in certain tumor cells and involved in tumor cell proliferation, differentiation, angiogenesis, and survival."}]